(Q57303564)

2

0 references

Claude Bouchard

8

object named as

Claude Bouchard

0 references

Tuomo Rankinen

3

object named as

Tuomo Rankinen

0 references

author name string

Hanna-Maaria Lakka

1

0 references

D.C. Rao

5

0 references

Arthur S. Leon

6

0 references

James S. Skinner

Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults

7

0 references

publication date

May 2006

0 references

published in

Vascular Pharmacology

0 references

volume

44

0 references

issue

5

0 references

page(s)

377-383

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Effect of physical activity on serum C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Tumor necrosis factor-alpha--308 G/A polymorphism in obese Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Association between physical activity and markers of inflammation in a healthy elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Excessive fat accumulation is associated with the TNFα -308 G/A promoter polymorphism in women but not in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Inflammatory markers and risk of developing type 2 diabetes in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Tumor necrosis factor-alpha -308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Physical activity and hemostatic and inflammatory variables in elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Reproducibility of anthropometric and body composition measurements: the HERITAGE Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Association of the TNF-alpha-308 (G-->A) polymorphism with self-reported history of childhood asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002

Polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.02.002